Advertisement
Case study| Volume 22, ISSUE 3, P558-562, May 2018

Download started.

Ok

Severe GABAA receptor encephalitis without seizures: A paediatric case successfully treated with early immunomodulation

  • Author Footnotes
    1 Statistical analysis conducted by Marc Nikolaus, MD, Department of Neuropaediatrics, Charité University Medicine, Berlin, Germany.
    Marc Nikolaus
    Footnotes
    1 Statistical analysis conducted by Marc Nikolaus, MD, Department of Neuropaediatrics, Charité University Medicine, Berlin, Germany.
    Affiliations
    Department of Neuropaediatrics, Charité University Medicine, Berlin, Germany
    Search for articles by this author
  • Ellen Knierim
    Affiliations
    Department of Neuropaediatrics, Charité University Medicine, Berlin, Germany
    Search for articles by this author
  • Christian Meisel
    Affiliations
    Department of Medical Immunology, Charité University Medicine, Berlin & Labor Berlin – Charité Vivantes, Berlin, Germany
    Search for articles by this author
  • Jakob Kreye
    Affiliations
    Department of Neurology, Charité University Medicine and German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
    Search for articles by this author
  • Harald Prüss
    Affiliations
    Department of Neurology, Charité University Medicine and German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
    Search for articles by this author
  • Dirk Schnabel
    Affiliations
    Center for Chronically Sick Children, Paediatric Endocrinology, Charité University Medicine, Berlin, Germany
    Search for articles by this author
  • Tilmann Kallinich
    Correspondence
    Corresponding author. Paediatric Pneumology and Immunology, Charité University Medicine, Berlin Augustenburger Platz 1, Mittelallee 8, 13353, Berlin, Germany. Fax: +49 30 450 566 931.
    Affiliations
    Center for Chronically Sick Children, Paediatric Endocrinology, Charité University Medicine, Berlin, Germany

    Paediatric Pneumology and Immunology, Charité University Medicine, Berlin and Charité University Medicine, Center for Chronically Sick Children, Berlin, Germany
    Search for articles by this author
  • Author Footnotes
    1 Statistical analysis conducted by Marc Nikolaus, MD, Department of Neuropaediatrics, Charité University Medicine, Berlin, Germany.
Published:January 09, 2018DOI:https://doi.org/10.1016/j.ejpn.2018.01.002

      Highlights

      • A paediatric case of GABAAR encephalitis without development of seizures despite severe phenotype.
      • A full recovery upon early immunosuppression unlike previous reports.
      • A report extending the phenotype of this rare disease.
      • A medical history raising questions about the aetiology of autoimmune encephalitis.

      Abstract

      Background

      Autoimmune-mediated processes are the driving force behind many neurological diseases. Autoimmune encephalitis, a group of syndromes, mediated by or at least associated with autoantibodies against neuronal tissue, have gained increasing importance especially in paediatric neurology. Since the first NMDAR encephalitis was described a growing number of patients with encephalopathy, seizures and psychiatric symptoms were found to suffer from treatable autoimmune disorders. Recently a severe form of encephalitis associated with GABAAR antibodies was described showing extensive MRI abnormalities and refractory seizures.

      Case

      We now describe a child with catatonia and encephalopathy due to antibodies against the GABAA receptor. It is a rare paediatric case without the development of seizures despite severe encephalopathy.

      Relevance

      The report extends the phenotype of this rare disease. It demonstrates a favourable outcome after introduction of an early and aggressive immunomodulatory therapy. Due to the child's history of previous viral meningitis, the case raises questions about the unrevealed mechanisms leading to autoimmune encephalitis, including the model of a viral trigger as discussed in Herpes infection and NMDAR encephalitis. Finally, it describes in detail the neuropsychological symptoms and cognitive functions during disease flare and recovery.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Paediatric Neurology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jacob T.C.
        • Moss S.J.
        • Jurd R.
        GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition.
        Nat Rev Neurosci. 2008; 9: 331-343https://doi.org/10.1038/nrn2370
        • Petit-Pedrol M.
        • Armangue T.
        • Peng X.
        • Bataller L.
        • Cellucci T.
        • Davis R.
        • et al.
        Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
        Lancet Neurol. 2014; 13: 276-286https://doi.org/10.1016/S1474-4422(13)70299-0
        • Ohkawa T.
        • Satake S.
        • Yokoi N.
        • Miyazaki Y.
        • Ohshita T.
        • Sobue G.
        • et al.
        Identification and characterization of GABAA receptor autoantibodies in autoimmune encephalitis.
        J Neurosci. 2014; 34: 8151-8163https://doi.org/10.1523/JNEUROSCI.4415-13.2014
        • Pettingill P.
        • Kramer H.B.
        • Coebergh J.A.
        • Pettingill R.
        • Maxwell S.
        • Nibber A.
        • et al.
        Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization.
        Neurology. 2015; 84: 1233-1241https://doi.org/10.1212/WNL.0000000000001326
        • Spatola M.
        • Petit-Pedrol M.
        • Simabukuro M.M.
        • Armangue T.
        • Castro F.J.
        • Barcelo Artigues M.I.
        • et al.
        Investigations in GABA Areceptor antibody-associated encephalitis.
        Neurology. 2017; 88: 1012-1020https://doi.org/10.1212/WNL.0000000000003713
        • Titulaer M.J.
        • McCracken L.
        • Gabilondo I.
        • Armangue T.
        • Glaser C.
        • Iizuka T.
        • et al.
        Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
        Lancet Neurol. 2013; 12: 157-165https://doi.org/10.1016/S1474-4422(12)70310-1
        • Scott H.S.
        • Heino M.
        • Peterson P.
        • Mittaz L.
        • Lalioti M.D.
        • Betterle C.
        • et al.
        Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins.
        Mol Endocrinol. 1998; 12: 1112-1119https://doi.org/10.1210/mend.12.8.0143
        • Tan I.L.
        • McArthur J.C.
        • Venkatesan A.
        • Nath A.
        Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised.
        Neurology. 2012; 79: 2125-2132https://doi.org/10.1212/WNL.0b013e3182752ceb
        • Prüss H.
        • Finke C.
        • Höltje M.
        • Hofmann J.
        • Klingbeil C.
        • Probst C.
        • et al.
        N-methyl- D-aspartate receptor antibodies in herpes simplex encephalitis.
        Ann Neurol. 2012; 72: 902-911https://doi.org/10.1002/ana.23689
        • Armangue T.
        • Leypoldt F.
        • Málaga I.
        • Raspall-Chaure M.
        • Marti I.
        • Nichter C.
        • et al.
        Herpes simplex virus encephalitis is a trigger of brain autoimmunity.
        Ann Neurol. 2014; 75: 317-323https://doi.org/10.1002/ana.24083
        • Pasquier Du R.
        Limbic encephalitis: another example of molecular mimicry?.
        Eur Neurol. 2007; 57: 191-192https://doi.org/10.1159/000099157